Biotech Breakout Trader Alert on Nasdaq

I just got a terrific surprise from my buddy Mark Messier at Biotech Breakout Trader. He’s decided to share another hot biotech trade that could bring you double- or triple-digit returns.
By: Rob Trader
 
Sept. 21, 2011 - PRLog -- I just got a terrific surprise from my buddy Mark Messier at Biotech Breakout Trader.  

He’s in a great mood thanks to the successful launch of his new Biotech Breakout Trader service, and he’s decided to share another hot biotech trade that could bring you double- or triple-digit returns.

However, this one requires fast action on your part because the catalyst is due in early October.

This time around the company is Exelixis, Inc. , and it has a pivotal Phase III trial going on for its new thyroid cancer drug.

This stock still has room to run, so Mark recommends getting in now and riding it for all you can over the next three weeks. Then, get out before the data is released.

Mark and I both recommend that you don’t invest more than 10% of your portfolio in Exelixis. Any more than that is just too risky for our taste. You’re far better off spreading your portfolio across a number of biotechs rather than putting too many of your eggs in one basket.

Exelixis and Celsion — the biotech Mark recommended a couple of days ago —are both excellent examples of the kind of small cap biotechs Mark regularly recommends to members of his Biotech Breakout Trader.  

They’re the kind of stocks that have helped him turn $7,480 into $289,635 over the last two and a half years.

Mark has a number of additional recommendations coming on line soon for his members — plus four or five in his recommended portfolio that are still good buys.

He’d love to share those trades with you, too, but they’re reserved for his members.

Fortunately, he’s still accepting members, so if you’d like to consider joining — and get access to all those additional picks — I urge you to check out his latest video that describes everything you receive as a member of Biotech Breakout Trader.

You can check it out here.

http://biorunupreview.com/fast-action-required-trade-alert-on-nasdaq-exel/

Full disclosure: Mark buys all the stocks he recommends. He already has a position in Exelixis, as do many of his members. However, he believes it still has room to run before the catalyst. Remember, as I mentioned above, you need to act fast.

If you’d like more picks like this — and the sell signals, too — then I urge you to watch Mark’s latest video and discover everything you get with Biotech Breakout Trader.

# # #

Forex Profit Multiplier | Brand New Forex Education & Training Course. Top ranking forex strategies. Best choice for your Forex Trading Software.
End
Best Selling Forex Tools PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share